Trial
NCT04131556
A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Shire
Collaborators
—
Condition
Healthy Volunteers
Intervention
Maribavir
Why stopped
The study was stopped because based on the planned interim analysis of the data of Part 1, palatability of both pediatric formulations was not acceptable.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-02